These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 16154259)
1. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model. She M; Jim Yeung SC Cancer Lett; 2006 Jul; 238(2):197-201. PubMed ID: 16154259 [TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. Xu G; Pan J; Martin C; Yeung SC J Clin Endocrinol Metab; 2001 Apr; 86(4):1769-77. PubMed ID: 11297616 [TBL] [Abstract][Full Text] [Related]
3. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model. Yeung SC; She M; Yang H; Pan J; Sun L; Chaplin D J Clin Endocrinol Metab; 2007 Aug; 92(8):2902-9. PubMed ID: 17550961 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. Pan J; Xu G; Yeung SC J Clin Endocrinol Metab; 2001 Oct; 86(10):4731-40. PubMed ID: 11600533 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells. Pan J; Huang H; Sun L; Fang B; Yeung SC J Clin Endocrinol Metab; 2005 Jun; 90(6):3583-91. PubMed ID: 15769983 [TBL] [Abstract][Full Text] [Related]
7. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. Yang HL; Pan JX; Sun L; Yeung SC J Clin Endocrinol Metab; 2003 Feb; 88(2):763-72. PubMed ID: 12574211 [TBL] [Abstract][Full Text] [Related]
8. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice]. Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869 [TBL] [Abstract][Full Text] [Related]
9. Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Copland JA; Marlow LA; Kurakata S; Fujiwara K; Wong AK; Kreinest PA; Williams SF; Haugen BR; Klopper JP; Smallridge RC Oncogene; 2006 Apr; 25(16):2304-17. PubMed ID: 16331265 [TBL] [Abstract][Full Text] [Related]
10. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer. Dackiw A; Pan J; Xu G; Yeung SC Surgery; 2005 Sep; 138(3):456-63. PubMed ID: 16213899 [TBL] [Abstract][Full Text] [Related]
11. Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl:protein transferase inhibitor. Ito T; Kawata S; Tamura S; Igura T; Nagase T; Miyagawa JI; Yamazaki E; Ishiguro H; Matasuzawa Y Jpn J Cancer Res; 1996 Feb; 87(2):113-6. PubMed ID: 8609057 [TBL] [Abstract][Full Text] [Related]
12. Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice. Kim S; Prichard CN; Younes MN; Yazici YD; Jasser SA; Bekele BN; Myers JN Clin Cancer Res; 2006 Jan; 12(2):600-7. PubMed ID: 16428506 [TBL] [Abstract][Full Text] [Related]
13. Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo. Taylor SA; Marrinan CH; Liu G; Nale L; Bishop WR; Kirschmeier P; Liu M; Long BJ Gynecol Oncol; 2008 Apr; 109(1):97-106. PubMed ID: 18237771 [TBL] [Abstract][Full Text] [Related]
14. Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G Endocr Relat Cancer; 2007 Sep; 14(3):839-45. PubMed ID: 17914112 [TBL] [Abstract][Full Text] [Related]
15. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice. Sugita M; Sugita H; Kaneki M Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin. Kainuma O; Asano T; Hasegawa M; Kenmochi T; Nakagohri T; Tokoro Y; Isono K Pancreas; 1997 Nov; 15(4):379-83. PubMed ID: 9361092 [TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model. Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138 [TBL] [Abstract][Full Text] [Related]